J. Bradley Rivet Net Worth & Insider Trades

J. Bradley Rivet - VP Marketing, Acura Pharmaceuticals, Inc

As of December 12, 2016

What is J. Bradley Rivet's Net Worth?

The current estimated net worth of Acura Pharmaceuticals, Inc's VP Marketing, J. Bradley Rivet, is estimated to be about $0.8 . J. Bradley Rivet owns about 2,000 units of Acura Pharmaceuticals, Inc common stock. In the last 5 years at Acura Pharmaceuticals, Inc, J. Bradley Rivet has sold an estimated value of $0 worth.

What is J. Bradley Rivet's Past Insider Trading?

J. Bradley Rivet's largest purchase order was 2,000 units , worth over $2.46K on May 19, 2014. In total, J. Bradley Rivet has made about 8 transactions over 5 years of their time at Acura Pharmaceuticals, Inc. J. Bradley Rivet usually trades in December, with the busiest year in 2014 and 2011.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

J. Bradley Rivet

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is J. Bradley Rivet's' Mailing Address?

  • Mailing address is C/o Acura Pharmaceuticals Inc, 616 N. North Court, Suite 120 Palatine IL 60067 IL

What are Acura Pharmaceuticals, Inc's Past Insider Trades?

Acura Pharmaceuticals, Inc's most recent insider trade came on January 2, 2018 by Claudius Llc, International Partners Galen III, Galen Employee Fund Iii Lp, Galen Management Llc and Partners Galen III who sold 2,195,734 units worth $219.57K . In the last 9 years, insiders at Acura Pharmaceuticals, Inc have sold an estimated value of $25.32M and bought an estimated value of $15.01M worth of shares. Insider trading is most common in January, with the busiest year in 2013. The most active traders at the company are Care Capital Ii Llc,  Care Capital Investments Ii Lp,  and Care Capital Offshore Investments Ii Lp .

ACURA PHARMACEUTICALS, INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...